186 related articles for article (PubMed ID: 11319181)
1. Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer.
Clifford JL; Sabichi AL; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):391-5. PubMed ID: 11319181
[TBL] [Abstract][Full Text] [Related]
2. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells.
Sun SY; Yue P; Kelloff GJ; Steele VE; Lippman SM; Hong WK; Lotan R
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):595-601. PubMed ID: 11401908
[TBL] [Abstract][Full Text] [Related]
3. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL
Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536
[TBL] [Abstract][Full Text] [Related]
4. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
Zou C; Liebert M; Zou C; Grossman HB; Lotan R
J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
[TBL] [Abstract][Full Text] [Related]
5. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R
Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines.
Oridate N; Lotan D; Xu XC; Hong WK; Lotan R
Clin Cancer Res; 1996 May; 2(5):855-63. PubMed ID: 9816241
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR).
Xia Y; Wong NS; Fong WF; Tideman H
Int J Cancer; 2002 Nov; 102(1):7-14. PubMed ID: 12353227
[TBL] [Abstract][Full Text] [Related]
9. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
[TBL] [Abstract][Full Text] [Related]
10. How retinoids regulate breast cancer cell proliferation and apoptosis.
Simeone AM; Tari AM
Cell Mol Life Sci; 2004 Jun; 61(12):1475-84. PubMed ID: 15197471
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cells.
Lim SJ; Simeone AM; Kim CK; Tari AM
Int J Cancer; 2002 Sep; 101(3):243-7. PubMed ID: 12209974
[TBL] [Abstract][Full Text] [Related]
12. The hydroxyl functional group of N-(4-hydroxyphenyl)retinamide mediates cellular uptake and cytotoxicity in premalignant and malignant human epithelial cells.
Hail N; Chen P; Wempe MF
Free Radic Biol Med; 2010 Dec; 49(12):2001-9. PubMed ID: 20923701
[TBL] [Abstract][Full Text] [Related]
13. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway.
Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E
Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855
[TBL] [Abstract][Full Text] [Related]
14. Implication of mitochondria-derived reactive oxygen species, cytochrome C and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.
Suzuki S; Higuchi M; Proske RJ; Oridate N; Hong WK; Lotan R
Oncogene; 1999 Nov; 18(46):6380-7. PubMed ID: 10597238
[TBL] [Abstract][Full Text] [Related]
15. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL).
Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z
Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979
[TBL] [Abstract][Full Text] [Related]
16. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl)retinamide-induced apoptosis.
Hail N; Lotan R
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1293-301. PubMed ID: 11142414
[TBL] [Abstract][Full Text] [Related]
18. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.
Oridate N; Suzuki S; Higuchi M; Mitchell MF; Hong WK; Lotan R
J Natl Cancer Inst; 1997 Aug; 89(16):1191-8. PubMed ID: 9274913
[TBL] [Abstract][Full Text] [Related]
19. Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl beta-glucuronide.
Formelli F; Barua AB; Olson JA
FASEB J; 1996 Jul; 10(9):1014-24. PubMed ID: 8801162
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.
Holmes WF; Soprano DR; Soprano KJ
J Biol Chem; 2002 Nov; 277(47):45408-19. PubMed ID: 12237293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]